Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedJun 21, 2024
DataAggregated Company Financials
Companies6
  • 7D-1.1%
  • 3M-1.3%
  • 1Y3.8%
  • YTDn/a

The Pharma industry has stayed flat over the last week. The past year has been better, since the industry has gained 3.6% in that time. Looking forward, earnings are forecast to decline by 17% per year.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 21 Jun 2024RM4.5bRM2.6bRM541.3m13.3x8.3x1.7x
Sun, 19 May 2024RM4.5bRM2.6bRM556.4m12.3x8.1x1.7x
Tue, 16 Apr 2024RM4.5bRM2.6bRM559.3m12.3x8.1x1.7x
Thu, 14 Mar 2024RM4.5bRM2.6bRM559.3m12.4x8x1.7x
Sat, 10 Feb 2024RM4.6bRM2.6bRM584.9m12.2x7.8x1.8x
Mon, 08 Jan 2024RM4.3bRM2.6bRM584.9m12.4x7.4x1.7x
Wed, 06 Dec 2023RM4.2bRM2.6bRM584.9m12.2x7.1x1.6x
Fri, 03 Nov 2023RM4.2bRM2.6bRM604.4m12.1x6.9x1.6x
Sun, 01 Oct 2023RM4.3bRM2.6bRM604.4m12.6x7.1x1.7x
Tue, 29 Aug 2023RM4.3bRM2.6bRM604.6m12.5x7.1x1.7x
Thu, 27 Jul 2023RM4.4bRM2.6bRM304.7m14.2x14.4x1.7x
Sat, 24 Jun 2023RM4.3bRM2.6bRM304.7m14.6x14.2x1.7x
Mon, 22 May 2023RM4.8bRM2.5bRM289.5m13.6x16.5x1.9x
Wed, 19 Apr 2023RM4.8bRM2.5bRM289.8m13.4x16.7x1.9x
Fri, 17 Mar 2023RM4.6bRM2.5bRM289.8m13.4x16x1.9x
Sun, 12 Feb 2023RM4.5bRM2.4bRM270.7m13.1x16.6x1.8x
Tue, 10 Jan 2023RM4.7bRM2.4bRM270.7m12.9x17.5x1.9x
Thu, 08 Dec 2022RM4.5bRM2.4bRM270.7m12x16.5x1.8x
Sat, 05 Nov 2022RM4.1bRM2.4bRM249.0m12.3x16.3x1.7x
Mon, 03 Oct 2022RM3.9bRM2.4bRM249.0m11.4x15.5x1.6x
Wed, 31 Aug 2022RM3.8bRM2.4bRM249.0m11.6x15.4x1.6x
Fri, 29 Jul 2022RM3.9bRM2.3bRM226.0m14x17.2x1.7x
Sun, 26 Jun 2022RM3.4bRM2.3bRM226.0m13.9x15.1x1.5x
Tue, 24 May 2022RM4.0bRM2.3bRM215.3m14.4x18.4x1.7x
Thu, 21 Apr 2022RM4.0bRM2.2bRM204.5m16.3x19.7x1.8x
Sat, 19 Mar 2022RM3.7bRM2.2bRM204.5m16.1x18x1.6x
Mon, 14 Feb 2022RM3.8bRM2.1bRM187.4m16.3x20.4x1.8x
Wed, 12 Jan 2022RM3.7bRM2.1bRM187.4m15.3x19.9x1.7x
Fri, 10 Dec 2021RM3.7bRM2.1bRM187.4m15.2x19.8x1.7x
Sun, 07 Nov 2021RM3.8bRM2.0bRM166.6m20.4x22.5x1.9x
Tue, 05 Oct 2021RM3.9bRM2.0bRM166.6m20.8x23.3x1.9x
Thu, 02 Sep 2021RM4.2bRM2.0bRM166.5m21.9x25.5x2.1x
Sat, 31 Jul 2021RM4.2bRM2.0bRM166.5m19.5x25.5x2.1x
Price to Earnings Ratio

26.9x


Total Market Cap: RM4.5bTotal Earnings: RM166.5mTotal Revenue: RM2.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 15.4x202220232024
Current Industry PE
  • Investors are pessimistic on the Malaysian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 8.3x which is lower than its 3-year average PE of 15.4x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 48% per year over the last three years.
  • Revenues for these companies have grown 9.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Malaysian Pharma compare with similar industries?

MY Market-1.49%
Healthcare-1.48%
Pharma-1.11%
Pharma-1.11%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KOTRA Kotra Industries BerhadRM4.340.2%
+RM1.5m
-17.6%PE14.2x
PLABS PeterLabs Holdings BerhadRM0.202.5%
+RM1.4m
10.8%PE16.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

RHONEMA

RM0.68

Rhone Ma Holdings Berhad

7D

-1.4%

1Y

-9.3%

YSPSAH

RM2.93

Y.S.P. Southeast Asia Holding Berhad

7D

-1.3%

1Y

18.1%

KOTRA

RM4.34

Kotra Industries Berhad

7D

0.2%

1Y

-17.6%

DPHARMA

RM1.24

Duopharma Biotech Berhad

7D

-0.8%

1Y

-5.3%

PLABS

RM0.20

PeterLabs Holdings Berhad

7D

2.5%

1Y

10.8%

AHEALTH

RM2.85

Apex Healthcare Berhad

7D

-1.7%

1Y

18.3%